Preparation and Characterization of Nanoparticles for Solubility and Dissolution Rate Enhancement of Meloxicam
暂无分享,去创建一个
[1] Jianfeng Chen,et al. Preparation of uniform prednisolone microcrystals by a controlled microprecipitation method. , 2007, International journal of pharmaceutics.
[2] Huibi Xu,et al. A facile nanoaggregation strategy for oral delivery of hydrophobic drugs by utilizing acid–base neutralization reactions , 2008, Nanotechnology.
[3] Huibi Xu,et al. Oleanolic acid nanosuspensions: preparation, in‐vitro characterization and enhanced hepatoprotective effect , 2005, The Journal of pharmacy and pharmacology.
[4] G. Ennas,et al. Diclofenac nanosuspensions: influence of preparation procedure and crystal form on drug dissolution behaviour. , 2009, International journal of pharmaceutics.
[5] R. Müller,et al. Nanosuspensions as particulate drug formulations in therapy. Rationale for development and what we can expect for the future. , 2001, Advanced drug delivery reviews.
[6] A. Müllertz,et al. Adsorption of pharmaceutical excipients onto microcrystals of siramesine hydrochloride: effects on physicochemical properties. , 2009, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[7] D. Türck,et al. Meloxicam oral suspension: a treatment alternative to solid meloxicam formulations , 2001, Inflammation Research.
[8] P Amsa,et al. Nanosuspensions: A Promising Drug Delivery Strategy , 2010 .
[9] Jonathan Brown,et al. Enhancement of oral bioavailability of an HIV-attachment inhibitor by nanosizing and amorphous formulation approaches. , 2009, International journal of pharmaceutics.
[10] Rainer H Müller,et al. Nanosuspensions: a promising formulation for the new phospholipase A2 inhibitor PX-18. , 2010, International journal of pharmaceutics.
[11] J Dressman,et al. Improving drug solubility for oral delivery using solid dispersions. , 2000, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[12] M. Fathy. Ca-alginate beads loaded with meloxicam: effect of alginate chemical composition on the properties of the beads and ulcerogenicity of the drug , 2006 .
[13] Sandip S Chavhan,et al. Nanosuspensions in drug delivery: recent advances, patent scenarios, and commercialization aspects. , 2011, Critical reviews in therapeutic drug carrier systems.
[14] Ranjita Shegokar,et al. Nanocrystals: industrially feasible multifunctional formulation technology for poorly soluble actives. , 2010, International journal of pharmaceutics.
[15] M. Mazzotti,et al. Miconazole nanosuspensions: Influence of formulation variables on particle size reduction and physical stability. , 2010, International journal of pharmaceutics.
[16] J. Hadgraft,et al. Formation and stabilisation of triclosan colloidal suspensions using supersaturated systems. , 2003, International journal of pharmaceutics.
[17] Jian Zhang,et al. Physical and chemical stability of drug nanoparticles. , 2011, Advanced drug delivery reviews.
[18] Filippos Kesisoglou,et al. Nanosizing--oral formulation development and biopharmaceutical evaluation. , 2007, Advanced drug delivery reviews.